Related Experiment Video

Updated: May 4, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

97.6K

Dynamic Stress Factor (DySF): A Significant Predictor of Severe Hypoglycemic Events in Children with Type 1 Diabetes

Ra Rawlings1, L Yuan2, H Shi3

  • 1Center for Computational Medicine and Bioinformatics, University of Michigan, USA ; Departments of Biophysics, University of Michigan, USA.

Journal of Diabetes & Metabolism
|December 19, 2013
PubMed

Insights

The new Dynamic Stress Factor (DySF) metric predicts severe hypoglycemia in children with type 1 diabetes. DySF quantifies glucose volatility, offering a valuable supplement to Hemoglobin A1c (HbA1c) for diabetes management.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Biomedical Engineering

Background:

  • Hemoglobin A1c (HbA1c) is the standard for diabetes management but doesn't capture glucose fluctuations.
  • Significant glycemic variability, including hyper- and hypoglycemia, impacts patient outcomes.
  • There is a need for quantitative metrics to complement HbA1c in diabetes care.

Purpose of the Study:

  • Introduce and evaluate the Dynamic Stress Factor (DySF), a novel metric for glycemic volatility.
  • Compare DySF with HbA1c and existing glucose variability metrics in predicting severe hypoglycemia.
  • Assess DySF's utility in managing type 1 diabetes, particularly in children.

Main Methods:

  • Calculated DySF, the daily weighted number of large monotonic glycemic transitions within one hour, for 441 type 1 diabetes subjects.
  • Quantified severe hypoglycemic episodes (HE) for all subjects.
  • Used logistic regression to evaluate DySF, HbA1c, SD, MAGE, MODD, and CONGA as predictors of HE.

Main Results:

  • DySF predicted severe hypoglycemia in children aged 8-14 years (p=0.018).
  • Lower DySF values correlated with an increased likelihood of severe hypoglycemia in this age group.
  • Patients experiencing severe HE had lower average DySF compared to those without HE.
  • DySF/mean showed preliminary predictive value for severe HE in patients with HbA1c ≤ 6.5% (p=0.062).

Conclusions:

  • DySF is a dynamic, quantitative measure of daily glucose volatility.
  • DySF can differentiate patient profiles within similar HbA1c strata.
  • DySF serves as a preliminary predictor of clinically severe hypoglycemia in children and well-controlled adults with diabetes.

More Related Videos

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.1K
Chronic Stress Shifts Effort-Related Choice Behavior in a Y-Maze Barrier Task in Mice09:37

Chronic Stress Shifts Effort-Related Choice Behavior in a Y-Maze Barrier Task in Mice

Published on: August 13, 2020

10.9K

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
30
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K